Israel Active

Israel’s Bonus Biogroup (see previously) has developed microscopic biodegradable tubes that run through an engineered transplant organ, supplying a steady flow of blood. This vastly increases the viability of artificial organs and the success rate of transplant operations.

In 2023, Bar-Ilan University Prof Shai Rahimipour (see previously) worked with Canadian scientists on a peptide therapy for Alzheimer’s disease. Now he is working with Italian scientists developing nanoparticles to attack an early version of the Amyloid-beta protein.

Prof. Ofra Benny, cofounder and CSO of Israel’s Orsight, has developed a small molecule that (in lab tests) stops the formation of excess blood vessels in the eye, thus preventing the worst effects of wet AMD. It also has prospects for use in cutting off blood supply to tumors.

Researchers at Tel Aviv University and Sheba Medical Center found that a diseased heart releases bubbles, called extracellular vesicles (sEVs). These travel through the bloodstream and promote the growth of cancer cells. Spironolactone stops sEVs and prevents cancer.

Congenital cytomegalovirus (cCMV) infection causes (often lifelong) health problems for one in every 1,000 newborns in the USA. Hadassah / Hebrew Uni researchers have developed an efficient cCMV PCR saliva-based screening test for early detection & treatment.

Neta from Kibbutz Kfar Aza was badly wounded by Hamas on Oct 7. Technion doctors created a unique orthotic device tailored specifically for Neta based on 3D scans of her leg, to aid her in walking while her ankle is unable to bear weight. It allows for adjustment as her leg heals.

Doctors at Hadassah’s hospitals in Jerusalem are using the latest technologies, like robot-assisted surgeries, 3D printing, and computer games, to treat wounded soldiers and civilians.  A robot can extract a bullet easily, without damage to other organs.

Israel’s FertilAI has developed Fertilane – an AI platform for clinicians, to offer solutions for better patient care throughout the entire fertility journey. It also includes an app to help patients throughout the complicated process of fertility treatments and to improve clinic-patient communication.

Researchers at Haifa University have discovered that sufferers of Parkinson’s disease have brain cells that are deficient in mRNA and proteins that build the extracellular matrix (ECM).  It is the ECM that provides brain cells with structural and biochemical support.  

The Israeli Phage Therapy Center (IPTC), led by two Hebrew University of Jerusalem professors, has used a bacteriophage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections in 16 patients. It has shown promising results with an 86.6% success rate.